Lucida Medical
Generated by Meeveem AI
"AI software that detects prostate cancer from MRI scans with expert level accuracy"
Cambridge
•11 - 50 Employees
•Digital Health
About Lucida Medical
Lucida Medical develops Prostate Intelligence (Pi), an AI software that analyses MRI scans to detect clinically significant prostate cancer. Pi achieves 95% sensitivity and 67% specificity, matching expert radiologist performance. The software identifies suspicious lesions, helping clinicians make faster diagnostic decisions while reducing unnecessary biopsies. Pi integrates into NHS diagnostic pathways and works across different MRI vendors and field strengths. The technology streamlines radiologist workflows in busy departments and enables same day biopsy pathways. By improving detection accuracy and reducing false positives, Pi helps healthcare systems deliver better outcomes while managing resource constraints.
15
Team Members
2019
Founded
Digital Health
Sector
Hybrid
Work Environment
Our Vision
A future where AI enables every healthcare system to detect cancer early, accurately, and equitably, giving patients the best chance of successful treatment and reducing unnecessary interventions for those without disease.
Our Mission
At Lucida Medical, our mission is to advance the prostate cancer pathway with AI that supports physicians, reduces costs, and delivers better care for patients.